Effect of methylprednisolone on small bowel, spleen and liver changes in a murine model of inflammatory bowel disease.

Banic, M; Brkic, T; Anic, B; Rotkvic, I; Grabarevic, Z; Duvnjak, M; Troskot, B; Mihatov, S

Banic, M; Brkic, T; Anic, B; Rotkvic, I; Grabarevic, Z; Duvnjak, M; Troskot, B; Mihatov, S.

Affiliation

Banic M; University Hospital Sestre Milosrdnice, Zagreb Department of Gastroenterology, Republic of Croatia.

Aliment Pharmacol Ther ; 7(2): 201-6, 1993 Apr.

Article in En | MEDLINE | ID: mdl-8485274

Subject(s)

Ileum/drug effects; Inflammatory Bowel Diseases/drug therapy; Liver/drug effects; Methylprednisolone/pharmacology; Spleen/drug effects; Animals; Disease Models, Animal; Ileum/immunology; Inflammatory Bowel Diseases/immunology; Leukocytes, Mononuclear/drug effects; Liver/immunology; Lymphocyte Activation/drug effects; Male; Mice; Mice, Inbred BALB C; Spleen/immunology

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Spleen / Methylprednisolone / Inflammatory Bowel Diseases / Ileum / Liver Limits: Animals Language: En Journal: Aliment Pharmacol Ther Journal subject: FARMACOLOGIA / GASTROENTEROLOGIA / TERAPIA POR MEDICAMENTOS Year: 1993 Document type: Article Country of publication: United kingdom

Search on Google

Add to My VHL

XML

PubMed Links